ERK1/2 therefore emerged as the candidate for the mediator of PTK6-regulated cellular motility in pancreatic cancer and we accordingly sought to determine whether the effects of PTK6 on cellular migration and invasion depend on ERK1/2 activity. This evidence concerns the gene MAPK3 and familial pancreatic carcinoma.